Agilent Expands Cell Analysis R&D Capabilities in Ireland
November 16 2018 - 11:44AM
Dow Jones News
Agilent Technologies Inc. (A) on Friday announced an extension
to its facility in Little Island, Ireland, which will focus on
developing advanced technologies for the analysis of live-cells in
real-time.
The company said the new facility will incorporate Luxcel
Biosciences, which Agilent acquired earlier this year. The addition
of Luxcel expands Agilent's cell analysis portfolio and brings
added capabilities through technology and research, the company
said.
Agilent said the complex will house two new laboratories.
--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
November 16, 2018 11:29 ET (16:29 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Mar 2024 to Apr 2024
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Apr 2023 to Apr 2024